Tamoxifen vs. Raloxifene for Breast Cancer Chemoprophylaxis: Longer-Term Data - Raloxifene for breast cancer
- Views: 701 67
Tamoxifen and raloxifene have been shown to reduce the risk of breast cancer in women with a higher than average risk, but these drugs can have their own risks and side effects. Both of these drugs block estrogen in breast cells, which is why they can be useful in lowering breast. On September 14, , the FDA announced approval of raloxifene for reducing the risk of invasive breast cancer in postmenopausal women.